
For Collegium Pharmaceutical Inc (COLL), investors can consider selling a $30.00 strike put option for a 1.64% annualized YieldBoost, with an 86% probability of expiring worthless, effectively targeting a $29.70 acquisition cost for shares currently trading at $42.88. Alternatively, a covered call strategy involving the $45.00 strike could generate a 13.34% return if shares are called away by June 2026, or a 13.74% annualized premium boost if the option expires worthless, with a 50% chance of the latter. These options strategies are presented against COLL's 39% trailing 12-month volatility, with implied volatilities of 52% for the put and 40% for the call.
The article details two distinct options strategies for Collegium Pharmaceutical Inc (COLL), currently trading at $42.88, aimed at generating income or achieving a discounted entry. A cash-secured put strategy involves selling the $30.00 strike put, yielding a 1.64% annualized return (YieldBoost) with an 86% probability of expiring worthless. This effectively targets a $29.70 acquisition cost for investors interested in owning COLL at a significant discount. Alternatively, a covered call strategy utilizing the $45.00 strike call, expiring June 2026, offers a potential 13.34% total return if COLL shares are called away. Should the option expire worthless, which has a 50% probability, investors would retain their shares and achieve a 13.74% annualized premium boost. This strategy is designed for current COLL shareholders seeking to enhance returns while capping potential upside. Notably, the implied volatility for the $30.00 put is 52%, significantly above COLL's 39% trailing 12-month actual volatility, suggesting a potentially rich premium for put sellers. The $45.00 call's implied volatility is 40%, closely aligning with historical levels. These strategies are presented in a mildly positive context, focusing on tactical opportunities rather than fundamental shifts in COLL's outlook.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment